Comparison of platforms for determining tumour mutational burden (TMB) in patients with non-small cell lung cancer (NSCLC)Jonathan Baden, Traci Pawlowski, Shubham Pant et al.|Annals of Oncology|2019Cited by 7
Comparison of a highly sensitive, tumor-informed Illumina whole genome sequencing research assay and a tumor-informed bespoke whole exome sequencing assay for molecular residual disease detection in CheckMate-77T (NCT 04025879).Jonathan Beer, Traci Pawlowski, Li Liu et al.|Journal of Clinical Oncology|2026Cited by 0